Identification of a novel immune signature for optimizing prognosis and treatment prediction in colorectal cancer

Background: Globally, colorectal cancer (CRC) is one of the most lethal malignant diseases. However, the currently approved therapeutic options for CRC failed to acquire satisfactory treatment efficacy. Tailoring therapeutic strategies for CRC individuals can provide new insights into personalized p...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yan, Li, Yiyi, Xia, Zijin, Zhang, Dun, Chen, Xiaomei, Wang, Xinyu, Liao, Jing, Yi, Wei, Chen, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714135/
https://www.ncbi.nlm.nih.gov/pubmed/34898475
http://dx.doi.org/10.18632/aging.203771

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714135/
https://www.ncbi.nlm.nih.gov/pubmed/34898475
http://dx.doi.org/10.18632/aging.203771

Ejemplares similares